Assay Platform for Clinically Relevant Metallo-β-lactamases

[Image: see text] Metallo-β-lactamases (MBLs) are a growing threat to the use of almost all clinically used β-lactam antibiotics. The identification of broad-spectrum MBL inhibitors is hampered by the lack of a suitable screening platform, consisting of appropriate substrates and a set of clinically...

Descripción completa

Detalles Bibliográficos
Autores principales: van Berkel, Sander S., Brem, Jürgen, Rydzik, Anna M., Salimraj, Ramya, Cain, Ricky, Verma, Anil, Owens, Raymond J., Fishwick, Colin W. G., Spencer, James, Schofield, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910272/
https://www.ncbi.nlm.nih.gov/pubmed/23898798
http://dx.doi.org/10.1021/jm400769b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910272/
https://www.ncbi.nlm.nih.gov/pubmed/23898798
http://dx.doi.org/10.1021/jm400769b

Ejemplares similares